866-997-4948(US-Canada Toll Free)

China Neurological Disorder Drugs Market Research Report 2017

Published By :

QYResearch

Published Date : Jan 2017

Category :

Pharmaceutical

No. of Pages : 104 Pages

This report studies Neurological Disorder Drugs in China market, focuses on the top players in China market, with capacity, production, price, revenue and market share for each manufacturer, covering
Novartis AG
GlaxoSmithKline plc
Merck & Co.
Bayer AG
AstraZeneca
Boehringer Ingelheim GmbH
Teva Pharmaceutical Industries Ltd.
F. Hoffmann-La Roche Ltd.

Market Segment by Regions (provinces), covering
South China
East China
Southwest China
Northeast China
North China
Central China
Northwest China
Split by product Type, with production, revenue, price, market share and growth rate of each type, can be divided into
Antipsychotic
Hypnotic & Sedative
Analgesics
Anticoagulants
Others
Split by Application, this report focuses on consumption, market share and growth rate of  Neurological Disorder Drugs in each application, can be divided into
Hospital
Clinic
Home

Table of Contents

1 Neurological Disorder Drugs Market Overview
1.1 Product Overview and Scope of Neurological Disorder Drugs
1.2 Neurological Disorder Drugs Segment by Type
1.2.1 China Production Market Share of Neurological Disorder Drugs Type in 2015
1.2.2 Antipsychotic
1.2.3 Hypnotic & Sedative
1.2.4 Analgesics
1.2.5 Anticoagulants
1.2.6 Others
1.3 Applications of Neurological Disorder Drugs
1.3.1 Neurological Disorder Drugs Consumption Market Share by Application in 2015
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Home
1.4 China Market Size (Value) of Neurological Disorder Drugs (2011-2021)
1.5 China Neurological Disorder Drugs Status and Outlook
1.6 Government Policies

2 China Neurological Disorder Drugs Market Competition by Manufacturers
2.1 China Neurological Disorder Drugs Capacity, Production and Share by Manufacturers (2015 and 2016)
2.2 China Neurological Disorder Drugs Revenue and Share by Manufacturers (2015 and 2016)
2.3 China Neurological Disorder Drugs Average Price by Manufacturers (2015 and 2016)
2.4 Manufacturers Neurological Disorder Drugs Manufacturing Base Distribution, Sales Area, Product Type
2.5 Neurological Disorder Drugs Market Competitive Situation and Trends
2.5.1 Neurological Disorder Drugs Market Concentration Rate
2.5.2 Neurological Disorder Drugs Market Share of Top 3 and Top 5 Manufacturers

3 China Neurological Disorder Drugs Manufacturers Profiles/Analysis
3.1 Novartis AG
3.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.1.2 Neurological Disorder Drugs Product Type, Application and Specification
3.1.2.1 Antipsychotic
3.1.2.2 Hypnotic & Sedative
3.1.3 Novartis AG Neurological Disorder Drugs Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.1.4 Main Business/Business Overview
3.2 GlaxoSmithKline plc
3.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.2.2 Neurological Disorder Drugs Product Type, Application and Specification
3.2.2.1 Antipsychotic
3.2.2.2 Hypnotic & Sedative
3.2.3 GlaxoSmithKline plc 104 Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.2.4 Main Business/Business Overview
3.3 Merck & Co.
3.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.3.2 Neurological Disorder Drugs Product Type, Application and Specification
3.3.2.1 Antipsychotic
3.3.2.2 Hypnotic & Sedative
3.3.3 Merck & Co. 108 Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.3.4 Main Business/Business Overview
3.4 Bayer AG
3.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.4.2 Neurological Disorder Drugs Product Type, Application and Specification
3.4.2.1 Antipsychotic
3.4.2.2 Hypnotic & Sedative
3.4.3 Bayer AG Jan Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.4.4 Main Business/Business Overview
3.5 AstraZeneca
3.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.5.2 Neurological Disorder Drugs Product Type, Application and Specification
3.5.2.1 Antipsychotic
3.5.2.2 Hypnotic & Sedative
3.5.3 AstraZeneca  Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.5.4 Main Business/Business Overview
3.6 Boehringer Ingelheim GmbH
3.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.6.2 Neurological Disorder Drugs Product Type, Application and Specification
3.6.2.1 Antipsychotic
3.6.2.2 Hypnotic & Sedative
3.6.3 Boehringer Ingelheim GmbH Million USD Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.6.4 Main Business/Business Overview
3.7 Teva Pharmaceutical Industries Ltd.
3.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.7.2 Neurological Disorder Drugs Product Type, Application and Specification
3.7.2.1 Antipsychotic
3.7.2.2 Hypnotic & Sedative
3.7.3 Teva Pharmaceutical Industries Ltd. Pharma & Healthcare Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.7.4 Main Business/Business Overview
3.8 F. Hoffmann-La Roche Ltd.
3.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.8.2 Neurological Disorder Drugs Product Type, Application and Specification
3.8.2.1 Antipsychotic
3.8.2.2 Hypnotic & Sedative
3.8.3 F. Hoffmann-La Roche Ltd.  Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.8.4 Main Business/Business Overview

4 China Neurological Disorder Drugs Capacity, Production, Revenue, Consumption, Export and Import (2011-2016)
4.1 China Neurological Disorder Drugs Capacity, Production and Growth (2011-2016)
4.2 China Neurological Disorder Drugs Revenue and Growth (2011-2016)
4.3 China Neurological Disorder Drugs Production, Consumption, Export and Import (2011-2016)

5 China Neurological Disorder Drugs Production, Revenue (Value), Price Trend by Type
5.1 China Neurological Disorder Drugs Production and Market Share by Type (2011-2016)
5.2 China Neurological Disorder Drugs Revenue and Market Share by Type (2011-2016)
5.3 China Neurological Disorder Drugs Price by Type (2011-2016)
5.4 China Neurological Disorder Drugs Production Growth by Type (2011-2016)

6 China Neurological Disorder Drugs Market Analysis by Application
6.1 China Neurological Disorder Drugs Consumption and Market Share by Application (2011-2016)
6.2 China Neurological Disorder Drugs Consumption Growth Rate by Application (2011-2016)
6.3 Market Drivers and Opportunities
6.3.1 Potential Application
6.3.2 Emerging Markets/Countries

7 ChinaNeurological Disorder Drugs Market Analysis by Regions (Provinces)
7.1 China Neurological Disorder Drugs Production, Production Value and Price by Regions (Provinces)(2011-2016)
7.1.1 China Neurological Disorder Drugs Production and Market Share by Regions (Provinces)(2011-2016)
7.1.2 China Neurological Disorder Drugs Production Value and Market Share by Regions (Provinces)(2011-2016)
7.1.3 China Neurological Disorder Drugs Sales Price by Regions (Provinces)(2011-2016)
7.2 China Neurological Disorder Drugs Consumption by Regions (Provinces)(2011-2016)
7.3 China Neurological Disorder Drugs Production, Consumption, Export and Import (2011-2016)

8 Neurological Disorder Drugs Manufacturing Cost Analysis
8.1 Neurological Disorder Drugs Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Neurological Disorder Drugs

9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 Neurological Disorder Drugs Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Neurological Disorder Drugs Major Manufacturers in 2015
9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List

11 Market Effect Factors Analysis
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 China Neurological Disorder Drugs Market Forecast (2016-2021)
12.1 China Neurological Disorder Drugs Capacity, Production, Revenue Forecast (2016-2021)
12.2 China Neurological Disorder Drugs Production, Import, Export and Consumption Forecast (2016-2021)
12.3 China Neurological Disorder Drugs Production Forecast by Type (2016-2021)
12.4 China Neurological Disorder Drugs Consumption Forecast by Application (2016-2021)
12.5 China Neurological Disorder Drugs Production, Consumption, Import and Export Forecast by Regions (Provinces)(2016-2021)
12.5.1 China Neurological Disorder Drugs Production Forecast by Regions (Provinces)(2016-2021)
12.5.2 China Neurological Disorder Drugs Consumption Forecast by Regions (Provinces)(2016-2021)
12.5.3 China Neurological Disorder Drugs Production, Consumption, Import and Export Forecast by Regions (Provinces)(2016-2021)
12.6 Neurological Disorder Drugs Price Forecast (2016-2021)

13 Research Findings and Conclusion

14 Appendix
Methodology
Analyst Introduction
Data Source

 

List of Table

List of Tables and Figures

Figure Picture of Neurological Disorder Drugs
Figure China Production Market Share of Neurological Disorder Drugs by Type in 2015
Figure Product Picture of Antipsychotic
Table Major Manufacturers of Antipsychotic
Figure Product Picture of Hypnotic & Sedative
Table Major Manufacturers of Hypnotic & Sedative
Figure Product Picture of Analgesics
Table Major Manufacturers of Analgesics
Figure Product Picture of Anticoagulants
Table Major Manufacturers of Anticoagulants
Figure Product Picture of Others
Table Major Manufacturers of Others
Table Neurological Disorder Drugs Consumption Market Share by Application in 2015
Figure Hospital Examples
Figure Clinic Examples
Figure Home Examples
Figure China Neurological Disorder Drugs Revenue (Million USD) and Growth Rate (2011-2021)
Table China Neurological Disorder Drugs Capacity of Key Manufacturers (2015 and 2016)
Table China Neurological Disorder Drugs Capacity Market Share of Key Manufacturers (2015 and 2016)
Figure China Neurological Disorder Drugs Capacity of Key Manufacturers in 2015
Figure China Neurological Disorder Drugs Capacity of Key Manufacturers in 2016
Table China Neurological Disorder Drugs Production of Key Manufacturers (2015 and 2016)
Table China Neurological Disorder Drugs Production Share by Manufacturers (2015 and 2016)
Figure 2015 Neurological Disorder Drugs Production Share by Manufacturers
Figure 2016 Neurological Disorder Drugs Production Share by Manufacturers
Table China Neurological Disorder Drugs Revenue (Million USD) by Manufacturers (2015 and 2016)
Table China Neurological Disorder Drugs Revenue Share by Manufacturers (2015 and 2016)
Table 2015 China Neurological Disorder Drugs Revenue Share by Manufacturers
Table 2016 China Neurological Disorder Drugs Revenue Share by Manufacturers
Table China Market Neurological Disorder Drugs Average Price of Key Manufacturers (2015 and 2016)
Figure China Market Neurological Disorder Drugs Average Price of Key Manufacturers in 2015
Table Manufacturers Neurological Disorder Drugs Manufacturing Base Distribution and Sales Area
Table Manufacturers Neurological Disorder Drugs Product Type
Figure Neurological Disorder Drugs Market Share of Top 3 Manufacturers
Figure Neurological Disorder Drugs Market Share of Top 5 Manufacturers
Table Novartis AG Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novartis AG Neurological Disorder Drugs Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Novartis AG Neurological Disorder Drugs Market Share (2011-2016)
Table GlaxoSmithKline plc Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table GlaxoSmithKline plc Neurological Disorder Drugs Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure GlaxoSmithKline plc Neurological Disorder Drugs Market Share (2011-2016)
Table Merck & Co. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Merck & Co. Neurological Disorder Drugs Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Merck & Co. Neurological Disorder Drugs Market Share (2011-2016)
Table Bayer AG Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bayer AG Neurological Disorder Drugs Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Bayer AG Neurological Disorder Drugs Market Share (2011-2016)
Table AstraZeneca Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table AstraZeneca Neurological Disorder Drugs Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure AstraZeneca Neurological Disorder Drugs Market Share (2011-2016)
Table Boehringer Ingelheim GmbH Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Boehringer Ingelheim GmbH Neurological Disorder Drugs Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Boehringer Ingelheim GmbH Neurological Disorder Drugs Market Share (2011-2016)
Table Teva Pharmaceutical Industries Ltd. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Teva Pharmaceutical Industries Ltd. Neurological Disorder Drugs Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Teva Pharmaceutical Industries Ltd. Neurological Disorder Drugs Market Share (2011-2016)
Table F. Hoffmann-La Roche Ltd. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table F. Hoffmann-La Roche Ltd. Neurological Disorder Drugs Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure F. Hoffmann-La Roche Ltd. Neurological Disorder Drugs Market Share (2011-2016)
Figure China Neurological Disorder Drugs Capacity, Production and Growth (2011-2016)
Figure China Neurological Disorder Drugs Revenue (Million USD) and Growth (2011-2016)
Table China Neurological Disorder Drugs Production, Consumption, Export and Import (2011-2016)
Table China Neurological Disorder Drugs Production by Type (2011-2016)
Table China Neurological Disorder Drugs Production Share by Type (2011-2016)
Figure Production Market Share of Neurological Disorder Drugs by Type (2011-2016)
Figure 2015 Production Market Share of Neurological Disorder Drugs by Type
Table China Neurological Disorder Drugs Revenue by Type (2011-2016)
Table China Neurological Disorder Drugs Revenue Share by Type (2011-2016)
Figure Production Revenue Share of Neurological Disorder Drugs by Type (2011-2016)
Figure 2015 Revenue Market Share of Neurological Disorder Drugs by Type
Table China Neurological Disorder Drugs Price by Type (2011-2016)
Figure China Neurological Disorder Drugs Production Growth by Type (2011-2016)
Table China Neurological Disorder Drugs Consumption by Application (2011-2016)
Table China Neurological Disorder Drugs Consumption Market Share by Application (2011-2016)
Figure China Neurological Disorder Drugs Consumption Market Share by Application in 2015
Table China Neurological Disorder Drugs Consumption Growth Rate by Application (2011-2016)
Figure China Neurological Disorder Drugs Consumption Growth Rate by Application (2011-2016)
Table China Neurological Disorder Drugs Production by Regions (Provinces)(2011-2016)
Table China Neurological Disorder Drugs Production Market Share by Regions (Provinces)(2011-2016)
Table China Neurological Disorder Drugs Production Value by Regions (Provinces)(2011-2016)
Table China Neurological Disorder Drugs Production Value Market Share by Regions (Provinces)(2011-2016)
Table China Neurological Disorder Drugs Sales Price by Regions (Provinces)(2011-2016)
Table China Neurological Disorder Drugs Consumption by Regions (Provinces)(2011-2016)
Table China Neurological Disorder Drugs Consumption Market Share by Regions (Provinces)(2011-2016)
Table China Neurological Disorder Drugs Production, Consumption, Export and Import (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Neurological Disorder Drugs
Figure Manufacturing Process Analysis of Neurological Disorder Drugs
Figure Neurological Disorder Drugs Industrial Chain Analysis
Table Raw Materials Sources of Neurological Disorder Drugs Major Manufacturers in 2015
Table Major Buyers of Neurological Disorder Drugs
Table Distributors/Traders List
Figure China Neurological Disorder Drugs Capacity, Production and Growth Rate Forecast (2016-2021)
Figure China Neurological Disorder Drugs Revenue and Growth Rate Forecast (2016-2021)
Table China Neurological Disorder Drugs Production, Import, Export and Consumption Forecast (2016-2021)
Table China Neurological Disorder Drugs Production Forecast by Type (2016-2021)
Table China Neurological Disorder Drugs Consumption Forecast by Application (2016-2021)
Table China Neurological Disorder Drugs Production Forecast by Regions (Provinces)(2016-2021)
Table China Neurological Disorder Drugs Consumption Forecast by Regions (Provinces)(2016-2021)
Table China Neurological Disorder Drugs Production, Consumption, Import and Export Forecast by Regions (Provinces)(2016-2021)

 

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *